Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
chronic lymphocytic leukemia (CLL)
.
Show all posts
Showing posts with label
chronic lymphocytic leukemia (CLL)
.
Show all posts
Wednesday, January 27, 2016
Ibrutinib more effective than traditional chemotherapy in older untreated patients with CLL
›
In continuation of my update on ibrutinib A multi-center, international, randomized, Phase III study of older untreated patients with...
Thursday, September 24, 2015
Ibrutinib (IMBRUVICA) improves survival in treatment-naïve patients with chronic lymphocytic leukemia
›
In continuation of my update on Ibrutinib Pharmacyclics LLC, an AbbVie company, announced that ibrutinib (IMBRUVICA®) improved p...
Wednesday, October 16, 2013
Phase 3 study of idelalisibin reports positive results in CLL patients
›
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its Phase 3 study (Study 116) evaluating idelalisib in previously-treated chronic...
›
Home
View web version